Van S. Tompkins, Ph.D.
Affiliations: | 2007 | University of Iowa, Iowa City, IA |
Area:
Molecular Biology, Cell BiologyGoogle:
"Van Tompkins"Parents
Sign in to add mentor| Dawn E. Quelle | grad student | 2007 | University of Iowa | |
| (Characterization of novel ARF binding proteins, Nuclear Interactor of ARF and Mdm2 (NIAM) and Partner of ARF (Parf).) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| O'Leary CA, Andrews RJ, Tompkins VS, et al. (2019) RNA structural analysis of the MYC mRNA reveals conserved motifs that affect gene expression. Plos One. 14: e0213758 |
| Gao M, Li B, Sun X, et al. (2017) Preclinical activity of DCZ3301, a novel aryl-guanidino compound in the therapy of multiple myeloma. Theranostics. 7: 3690-3699 |
| Rabellino A, Melegari M, Tompkins VS, et al. (2016) PIAS1 Promotes Lymphomagenesis through MYC Upregulation. Cell Reports |
| Gu C, Yang Y, Sompallae R, et al. (2015) FOXM1 is a therapeutic target for high-risk multiple myeloma. Leukemia |
| Tompkins VS, Rosean TR, Holman CJ, et al. (2015) Adoptive B-cell transfer mouse model of human myeloma. Leukemia |
| Han SS, Tompkins VS, Son DJ, et al. (2015) CDKN1A and FANCD2 are potential oncotargets in Burkitt lymphoma and multiple myeloma. Experimental Hematology & Oncology. 4: 9 |
| Rosean TR, Tompkins VS, Olivier AK, et al. (2015) The tumor microenvironment is the main source of IL-6 for plasma cell tumor development in mice. Leukemia. 29: 233-7 |
| Rosean TR, Tompkins VS, Sompallae R, et al. (2015) Abstract A04: The tumor microenvironment is the main source of IL-6 for plasmacytoma development in mice. Clinical Cancer Research. 21 |
| Reed SM, Hagen J, Muniz VP, et al. (2014) NIAM-deficient mice are predisposed to the development of proliferative lesions including B-cell lymphomas. Plos One. 9: e112126 |
| Eckers JC, Kalen AL, Sarsour EH, et al. (2014) Forkhead box M1 regulates quiescence-associated radioresistance of human head and neck squamous carcinoma cells. Radiation Research. 182: 420-9 |